• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Kidney Injury in Patients Treated with Immune Checkpoint Inhibitors Does Not Meet KDIGO-AKI Criteria.免疫检查点抑制剂治疗患者的肾损伤不符合 KDIGO-AKI 标准。
Kidney360. 2021 Dec 21;3(3):524-529. doi: 10.34067/KID.0006752021. eCollection 2022 Mar 31.
2
The Role of Kidney Biopsy in Immune Checkpoint Inhibitor-Associated AKI.肾活检在免疫检查点抑制剂相关性 AKI 中的作用。
Kidney360. 2022 Jan 13;3(3):530-533. doi: 10.34067/KID.0000232022. eCollection 2022 Mar 31.
3
Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis.免疫检查点抑制剂治疗黑色素瘤患者急性肾损伤的发生率、预测因素和生存影响：10 年单中心分析。
Oncoimmunology. 2021 May 23;10(1):1927313. doi: 10.1080/2162402X.2021.1927313.
4
The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors.免疫检查点抑制剂治疗患者的急性肾损伤的发生率和风险因素。
Anticancer Drugs. 2023 Jul 1;34(6):783-790. doi: 10.1097/CAD.0000000000001463. Epub 2022 Dec 19.
5
Acute kidney injury in patients receiving immune checkpoint inhibitors: a retrospective real-world study.接受免疫检查点抑制剂治疗的患者的急性肾损伤：一项回顾性真实世界研究。
Eur J Cancer. 2023 Sep;191:112967. doi: 10.1016/j.ejca.2023.112967. Epub 2023 Jul 5.
6
Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study.免疫检查点抑制剂在临床实践中的肾脏不良反应：ImmuNoTox 研究。
Eur J Cancer. 2021 Apr;147:29-39. doi: 10.1016/j.ejca.2021.01.005. Epub 2021 Feb 16.
7
Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: COMMENTARY.对于发生免疫检查点抑制剂相关急性肾损伤的患者，再次激发是否合适？：评论
Kidney360. 2021 Sep 17;3(5):806-808. doi: 10.34067/KID.0005592021. eCollection 2022 May 26.
8
Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: PRO.对于发生免疫检查点抑制剂相关急性肾损伤的患者，再次激发是否合适？：正方观点。
Kidney360. 2021 Sep 17;3(5):799-802. doi: 10.34067/KID.0003962021. eCollection 2022 May 26.
9
Combination therapy with immune check point inhibitors and acute kidney injury.免疫检查点抑制剂与急性肾损伤的联合治疗
Acta Oncol. 2023 Feb;62(2):121-125. doi: 10.1080/0284186X.2023.2176255. Epub 2023 Feb 8.
10
Immune checkpoint inhibitors and acute kidney injury.免疫检查点抑制剂与急性肾损伤。
Front Immunol. 2024 Feb 23;15:1353339. doi: 10.3389/fimmu.2024.1353339. eCollection 2024.

引用本文的文献

1
The differentiation and intervention strategies for acute kidney injury after or induced by immune checkpoint inhibitors.免疫检查点抑制剂治疗后或所致急性肾损伤的鉴别与干预策略
Am J Cancer Res. 2025 Apr 15;15(4):1480-1493. doi: 10.62347/JECH8448. eCollection 2025.

免疫检查点抑制剂治疗患者的肾损伤不符合 KDIGO-AKI 标准。

Kidney Injury in Patients Treated with Immune Checkpoint Inhibitors Does Not Meet KDIGO-AKI Criteria.

机构信息

Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.

Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.

出版信息

Kidney360. 2021 Dec 21;3(3):524-529. doi: 10.34067/KID.0006752021. eCollection 2022 Mar 31.

DOI:10.34067/KID.0006752021
PMID:35582168
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9034820/
Abstract

Kidney injury in patients treated with immune checkpoint inhibitors develops gradually and often does not meet the Kidney Disease Improving Global Outcomes criteria for AKI.Proper classification of kidney injury could prevent the development of CKD and improve continued oncologic treatment.

摘要

接受免疫检查点抑制剂治疗的患者的肾损伤逐渐发展，且通常不符合急性肾损伤改善全球结局标准。正确的肾损伤分类可预防 CKD 的发生并改善持续的肿瘤治疗。